| 2026-10-21 | Herabstufung | RBC Capital Mkts | Sector Perform → Underperform |
| 2026-10-16 | Eingeleitet | Citigroup | Buy |
| 2026-09-30 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2026-08-17 | Hochstufung | Berenberg | Hold → Buy |
| 2026-07-27 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-05-21 | Herabstufung | Berenberg | Buy → Hold |
| 2026-05-18 | Eingeleitet | Jefferies | Underperform |
| 2026-04-01 | Eingeleitet | Berenberg | Buy |
| 2026-01-27 | Herabstufung | Arete | Buy → Neutral |
| 2026-01-23 | Herabstufung | HSBC Securities | Buy → Hold |
| 2026-01-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2026-01-06 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2026-01-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-10-24 | Bestätigt | TD Cowen | Buy |
| 2025-10-06 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-07-25 | Bestätigt | TD Cowen | Buy |
| 2025-07-11 | Bestätigt | TD Cowen | Buy |
| 2025-06-09 | Herabstufung | Goldman | Buy → Neutral |
| 2025-04-25 | Bestätigt | TD Cowen | Buy |
| 2025-04-23 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2025-04-15 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-02-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2025-01-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-12-05 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-11-12 | Resumed | Loop Capital | Buy |
| 2024-11-01 | Bestätigt | TD Cowen | Buy |
| 2024-10-15 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-10-11 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-10-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-10-04 | Herabstufung | UBS | Buy → Neutral |
| 2024-10-02 | Herabstufung | Exane BNP Paribas | Neutral → Underperform |
| 2024-09-10 | Resumed | Deutsche Bank | Hold |
| 2024-09-05 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-05 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-08-05 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2024-08-02 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-08-01 | Herabstufung | Fox Advisors | Overweight → Equal Weight |
| 2024-07-31 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-04-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-04-26 | Bestätigt | TD Cowen | Buy |
| 2024-04-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-03-15 | Eingeleitet | Piper Sandler | Neutral |
| 2024-01-26 | Bestätigt | TD Cowen | Outperform |
| 2024-01-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-01-04 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-01-03 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-09-13 | Eingeleitet | UBS | Buy |
| 2023-07-25 | Resumed | Morgan Stanley | Equal-Weight |
| 2023-06-13 | Resumed | Citigroup | Buy |
| 2023-06-07 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2023-05-05 | Eingeleitet | Berenberg | Buy |
| 2023-04-28 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-04-19 | Eingeleitet | Daiwa Securities | Buy |
| 2023-02-15 | Eingeleitet | Barclays | Overweight |
| 2023-01-25 | Eingeleitet | Loop Capital | Buy |
| 2023-01-18 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-13 | Eingeleitet | JP Morgan | Overweight |
| 2022-12-01 | Eingeleitet | New Street | Buy |
| 2022-11-21 | Eingeleitet | BofA Securities | Neutral |
| 2022-11-21 | Eingeleitet | Citigroup | Buy |
| 2022-11-21 | Eingeleitet | Cowen | Outperform |
| 2022-11-21 | Eingeleitet | Evercore ISI | Outperform |
| 2022-11-21 | Eingeleitet | Goldman | Buy |
| 2022-11-21 | Eingeleitet | Mizuho | Buy |
| 2022-11-21 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-11-21 | Eingeleitet | Needham | Buy |
| 2022-11-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-11-21 | Eingeleitet | Raymond James | Strong Buy |
| 2022-11-21 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-11-15 | Eingeleitet | Robert W. Baird | Outperform |
MBLY
